Article
In vivo deletion of a GWAS-identified Myb distal enhancer acts on Myb expression, globin switching, and clinical erythroid parameters in β-thalassemia.
Scientific reports - 15 Mar 2025
Deleuze Virginie, Stephen Tharshana, Salma Mohammad, Orfeo Cédric, Jorna Ruud, Maas Alex, Barroca Vilma, Arcangeli Marie-Laure, Lecellier Charles-Henri, Andrieu-Soler Charlotte, Grosveld Frank, Soler Eric
Abstract excerpt
Genome-wide association studies (GWAS) have identified numerous genetic variants linked to human diseases, mostly located in non-coding regions of the genome, particularly in putative enhancers. However, functional assessment of the non-coding GWAS variants has progressed at slow pace, since the functions of the vast majority of genomic enhancers have not been defined, impeding interpretation of...
Read the complete abstract on PubMedTopics
- beta-Thalassemia
- Animals
- Enhancer Elements, Genetic
- Genome-Wide Association Study
- Mice
